Aggressive resection of frequent peritoneal recurrences in colorectal cancer contributes to long-term survival

被引：2

作者：

Komori, Koji ^{[1
]}

Kinoshita, Takashi ^{[1
]}

Taihei, Oshiro ^{[1
]}

Ito, Seiji ^{[1
]}

Abe, Tetsuya ^{[1
]}

Senda, Yoshiki ^{[1
]}

Misawa, Kazunari ^{[1
]}

Ito, Yuichi ^{[1
]}

Uemura, Norihisa ^{[1
]}

Natsume, Seiji ^{[1
]}

Kawakami, Jiro ^{[1
]}

Ouchi, Akira ^{[1
]}

Tsutsuyama, Masayuki ^{[1
]}

Hosoi, Takahiro ^{[1
]}

Shigeyoshi, Itaru ^{[1
]}

Akazawa, Tomoyuki ^{[1
]}

Hayashi, Daisuke ^{[1
]}

Tanaka, Hideharu ^{[1
]}

Shimizu, Yasuhiro ^{[1
]}

机构：

[1] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi, Japan

来源：

Nagoya Journal of Medical Science | 2016年 / 78卷 / 04期

关键词：

aggressive resection; frequent peritoneal recurrences; colorectal cancer; INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; PLUS BEVACIZUMAB; CARCINOMATOSIS; FLUOROURACIL; LEUCOVORIN; ORIGIN; TRIAL;

D O I：

10.18999/nagjms.78.4.501

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

We report a long-term survivor of colorectal cancer who underwent aggressive, frequent resection for peritoneal recurrences. A 58-year-old woman was diagnosed with descending colon cancer. Resection of the descending colon along with lymph node dissection was performed in September 2006. The pathological findings revealed Stage IIA colorectal cancer. The following peritoneal recurrences were removed: two in July 2007, two in the omental fat and two in the pouch of Douglas in June 2008 resected by low anterior resection of the rectum, one in the uterus and right ovarian recurrence resected via bilateral adnexectomy and Hartmann's procedure in May 2011, and one in the ascending colon by partial resection of the colon wall in December 2011. Postoperative adjuvant chemotherapy (uracil and tegafur/leucovorin, fluorouracil/levofolinate/oxaliplatin/bevacizumab, 5-fluorouracil/leucovorin/bevacizumab, irinotecan/bevacizumab, and irinotecan/panitumumab) was administered. The patient did not desire postoperative adjuvant chemotherapy after the fourth operation. The long-term survival was 6 years and 7 months.

引用

页码：501 / 506

页数：6

共 8 条

[1]

Asano Tomonari, 2012, Gan To Kagaku Ryoho, V39, P1147

[2] Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies [J].

Bretcha-Boix, Pedro ;

Farre-Alegre, Jose ;

Sureda, Manuel ;

Dussan, Carlos ;

Perez Ruixo, Juan Jose ;

Brugarolas Masllorens, Antonio .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (06) :437-442

[3] Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin [J].

Cravioto-Villanueva, Adrian ;

Cavazos, Magdalena ;

Luna-Perez, Pedro ;

Martinez-Gomez, Hector ;

Lourdes Ramirez, Maria ;

Solorzano, Juan ;

Montiel, Hermelindo ;

Esquivel, Jesus .

SURGERY TODAY, 2016, 46 (08) :979-984

[4] A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients [J].

Nishina, Tomohiro ;

Takano, Yoshinao ;

Denda, Tadamichi ;

Yasui, Hisateru ;

Takeda, Koji ;

Ura, Takashi ;

Esaki, Taito ;

Okuyama, Yusuke ;

Kondo, Ken ;

Takahashi, Yasuo ;

Sugiyama, Yasuyuki ;

Muro, Kei .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (11) :1080-1086

[5] Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database [J].

Ozawa, Heita ;

Kotake, Kenjiro ;

Kobayashi, Hirotoshi ;

Sugihara, Kenichi .

SURGERY TODAY, 2014, 44 (09) :1643-1650

[6] Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205 [J].

Shimada, Yasuhiro ;

Hamaguchi, Tetsuya ;

Mizusawa, Junki ;

Saito, Norio ;

Kanemitsu, Yukihide ;

Takiguchi, Nobuhiro ;

Ohue, Masayuki ;

Kato, Takeshi ;

Takii, Yasumasa ;

Sato, Toshihiko ;

Tomita, Naohiro ;

Yamaguchi, Shigeki ;

Akaike, Makoto ;

Mishima, Hideyuki ;

Kubo, Yoshiro ;

Nakamura, Kenichi ;

Fukuda, Haruhiko ;

Moriya, Yoshihiro .

EUROPEAN JOURNAL OF CANCER, 2014, 50 (13) :2231-2240

[7] Japanese Society for Cancer of the Colon and Rectum (JS']JSCCR) Guidelines 2014 for treatment of colorectal cancer [J].

Watanabe, Toshiaki ;

Itabashi, Michio ;

Shimada, Yasuhiro ;

Tanaka, Shinji ;

Ito, Yoshinori ;

Ajioka, Yoichi ;

Hamaguchi, Tetsuya ;

Hyodo, Ichinosuke ;

Igarashi, Masahiro ;

Ishida, Hideyuki ;

Ishihara, Soichiro ;

Ishiguro, Megumi ;

Kanemitsu, Yukihide ;

Kokudo, Norihiro ;

Muro, Kei ;

Ochiai, Atsushi ;

Oguchi, Masahiko ;

Ohkura, Yasuo ;

Saito, Yutaka ;

Sakai, Yoshiharu ;

Ueno, Hideki ;

Yoshino, Takayuki ;

Boku, Narikazu ;

Fujimori, Takahiro ;

Koinuma, Nobuo ;

Morita, Takayuki ;

Nishimura, Genichi ;

Sakata, Yuh ;

Takahashi, Keiichi ;

Tsuruta, Osamu ;

Yamaguchi, Toshiharu ;

Yoshida, Masahiro ;

Yamaguchi, Naohiko ;

Kotake, Kenjiro ;

Sugihara, Kenichi .

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (02) :207-239

[8] Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial [J].

Yamada, Yasuhide ;

Takahari, Daisuke ;

Matsumoto, Hiroshi ;

Baba, Hideo ;

Nakamura, Masato ;

Yoshida, Kazuhiro ;

Yoshida, Motoki ;

Iwamoto, Shigeyoshi ;

Shimada, Ken ;

Komatsu, Yoshito ;

Sasaki, Yasutsuna ;

Satoh, Taroh ;

Takahashi, Keiichi ;

Mishima, Hideyuki ;

Muro, Kei ;

Watanabe, Masahiko ;

Sakata, Yuh ;

Morita, Satoshi ;

Shimada, Yasuhiro ;

Sugihara, Kenichi .

LANCET ONCOLOGY, 2013, 14 (13) :1278-1286

← 1 →